Sweet relief? candy and honey may shield salivary glands from radiation damage
NCT ID NCT01833650
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This trial tests whether sucking lemon candy and using honey mouthwash can reduce salivary gland damage caused by radioiodine therapy for thyroid cancer. About 120 adults who have had their thyroid removed and are about to receive radioiodine will be randomly assigned to the candy-and-honey routine or standard care. The goal is to see if these simple, everyday products can lower the risk of painful gland inflammation and dry mouth.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- lemon candy and thymus honey mouthwash
- What this could lead to
- If it works, this simple, low-cost approach could help prevent dry mouth and salivary gland damage in people undergoing radioiodine therapy for thyroid cancer.
- What could go wrong
- This is a small, early-stage trial. The benefit may be modest, and honey is not suitable for people with diabetes or honey allergies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
120 people
The number who actually took part.
- Started
-
Feb 2018
- Finished
-
Aug 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * \>18 years old * They had a histological diagnosis of papillary, follicular, medullary or anaplastic thyroid cancer * They had undergone total thyroidectomy * They were able to provide consent Exclusion Criteria: * patients who had distant metastases, * a history of salivary-gland disorders, * collagen tissue disease * diabetes mellitus, * previous radioiodine therapy or external radiation to the head or neck * allergy to the honey
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Thyroid cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bank of Cyprus Oncology
Nicosia, Nicosia, 2006, Cyprus
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light-Based probe aims to spot thyroid cancer faster
- Mapping how thyroid tumors spread and what surgery leaves behind
- Can a video keep thyroid cancer patients on track after surgery?
- Can doctors safely watch small thyroid cancers instead of removing them?
- Can heat replace the scalpel for small thyroid tumors?
- Thyroid surgery under the microscope: what 3,000 real operations reveal